Deciphering the Tumor-Immune-Microbe Interactions in HPV-Negative Head and Neck Cancer

Genes (Basel). 2023 Aug 8;14(8):1599. doi: 10.3390/genes14081599.

Abstract

Patients with human papillomavirus-negative head and neck squamous cell carcinoma (HPV-negative HNSCC) have worse outcomes than HPV-positive HNSCC. In our study, we used a published dataset and investigated the microbes enriched in molecularly classified tumor groups. We showed that microbial signatures could distinguish Hypoxia/Immune phenotypes similar to the gene expression signatures. Furthermore, we identified three highly-correlated microbes with immune processes that are crucial for immunotherapy response. The survival of patients in a molecularly heterogenous group shows significant differences based on the co-abundance of the three microbes. Overall, we present evidence that tumor-associated microbiota are critical components of the tumor ecosystem that may impact tumor microenvironment and immunotherapy response. The results of our study warrant future investigation to experimentally validate the conclusions, which have significant impacts on clinical decision-making, such as treatment selection.

Keywords: head and neck cancer; tumor microenvironment; tumor-associated microbes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Carcinoma, Squamous Cell*
  • Head and Neck Neoplasms* / genetics
  • Humans
  • Microbiota*
  • Papillomavirus Infections* / genetics
  • Squamous Cell Carcinoma of Head and Neck / genetics
  • Tumor Microenvironment / genetics